These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34568129)

  • 1. Dynamic profile and clinical implications of hematological and immunological parameters in COVID-19 patients. A retrospective study.
    Suryawanshi SY; Priya S; Sinha SS; Soni S; Haidry N; Verma S; Singh S
    J Family Med Prim Care; 2021 Jul; 10(7):2518-2523. PubMed ID: 34568129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Hematological and Immunological Parameters in COVID-19 Patients.
    Kumar A; Sepolia S; Shilpa RH; Rezayani G; Kumari S; Aastha ; Gupta S
    J Pharm Bioallied Sci; 2021; 13(2):238-243. PubMed ID: 34349485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Assessment of Hematological Parameters as Predictive Biomarkers for Disease Severity and Prognosis in COVID-19 Patients: A Longitudinal Study.
    Patange AP; Desai JV; Pujari B; Marwah A; Dey A
    Cureus; 2024 Jul; 16(7):e63593. PubMed ID: 39087175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting.
    Kruglova TS; Fomina DS
    Ter Arkh; 2022 Dec; 94(11):1294-1302. PubMed ID: 37167168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.
    Ding X; Yu Y; Lu B; Huo J; Chen M; Kang Y; Lou J; Liu Z
    Clin Chem Lab Med; 2020 Jul; 58(8):1365-1371. PubMed ID: 32441666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
    Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
    PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.
    Zhong Y; Cao Y; Zhong X; Peng Z; Jiang S; Tang T; Chen H; Li X; Xia Y; Cheng Y; Zhao X
    Am J Obstet Gynecol; 2021 Apr; 224(4):393.e1-393.e25. PubMed ID: 33098813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematological Profile with Peripheral Blood Smear Morphology of Admitted COVID-19 Infected Patients: A Study at a COVID Dedicated Hospital in Kashmir.
    Sarna JS; Shafat M; Shafi A; Kour H; Sahaf B; Shafi A
    J Assoc Physicians India; 2022 Dec; 70(12):11-12. PubMed ID: 37355968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of hematological parameters in the stratification of COVID-19 disease severity.
    Taj S; Kashif A; Arzinda Fatima S; Imran S; Lone A; Ahmed Q
    Ann Med Surg (Lond); 2021 Feb; 62():68-72. PubMed ID: 33437468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.
    Bolondi G; Russo E; Gamberini E; Circelli A; Meca MCC; Brogi E; Viola L; Bissoni L; Poletti V; Agnoletti V
    World J Emerg Surg; 2020 Jun; 15(1):41. PubMed ID: 32605582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and Hematological Response in COVID-19.
    Słomka A; Martucci G; Raffa GM; Malvindi PG; Żekanowska E; Lorusso R; Suwalski P; Kowalewski M
    Adv Exp Med Biol; 2021; 1352():73-86. PubMed ID: 35132595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematological Profile in COVID-19 Infection Among Patients in a Tertiary Care Hospital in Tamil Nadu, South India.
    Chandran N; Sigamani K; Khadeja Bi A
    Cureus; 2022 Oct; 14(10):e30731. PubMed ID: 36457636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Levels of Peripheral CD3
    Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
    Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Immune, Inflammatory and Hematological Response in COVID-19 Patients, According to the Severity of the Disease.
    Trofin F; Nastase EV; Vâță A; Iancu LS; Luncă C; Buzilă ER; Vlad MA; Dorneanu OS
    Microorganisms; 2023 Jan; 11(2):. PubMed ID: 36838284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.